Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic | Patent Number 06740669

US 06740669 B1
Application Number9125329
Publication Number-
Pendency5 years, 8 months, 21 days
Filled DateSep 8, 1998
Priority DateJun 8, 1998
Publication Date-
Expiration DateJun 8, 2018
Inventor/ApplicantsUrs Christoph Hofmeier
Walter Scherrer
Andreas Burkhard
Robert Portmann
Martin Szelagiewicz
ExaminesMORRIS, PATRICIA L
Art Unit1625
Technology Center1600
Assignments
Novartis Pharma Ag
Current
Novartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.